U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H32F3N3O5
Molecular Weight 499.5232
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ZD-0892

SMILES

COC1=CC=C(C=C1)C(=O)N[C@@H](C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(C)C)C(=O)C(F)(F)F

InChI

InChIKey=PNILZVBINXNWHW-FHWLQOOXSA-N
InChI=1S/C24H32F3N3O5/c1-13(2)18(20(31)24(25,26)27)28-22(33)17-7-6-12-30(17)23(34)19(14(3)4)29-21(32)15-8-10-16(35-5)11-9-15/h8-11,13-14,17-19H,6-7,12H2,1-5H3,(H,28,33)(H,29,32)/t17-,18-,19-/m0/s1

HIDE SMILES / InChI

Molecular Formula C24H32F3N3O5
Molecular Weight 499.5232
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.
2005 May
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.
2005 May 5
Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 10:29:47 GMT 2023
Edited
by admin
on Sat Dec 16 10:29:47 GMT 2023
Record UNII
KXL5BC5A6F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZD-0892
Code English
ZD0892
Code English
L-PROLINAMIDE, N-(4-METHOXYBENZOYL)-L-VALYL-N-((1S)-3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPROPYL)-
Systematic Name English
L-PROLINAMIDE, N-(4-METHOXYBENZOYL)-L-VALYL-N-(3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPROPYL)-, (S)-
Systematic Name English
N-(4-METHOXYBENZOYL)-L-VALYL)-N-((1S)-3,3,3-TR IFLUOR-1-ISOPROPYL2-OXOPROPYL)-L-PROLINAMIDE
Systematic Name English
Code System Code Type Description
PUBCHEM
9892148
Created by admin on Sat Dec 16 10:29:48 GMT 2023 , Edited by admin on Sat Dec 16 10:29:48 GMT 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
ZD 0892
Created by admin on Sat Dec 16 10:29:48 GMT 2023 , Edited by admin on Sat Dec 16 10:29:48 GMT 2023
PRIMARY ZD 0892 is a human neutrophil elastase inhibitor that was under development with AstraZeneca (formed by the merger of Astra and Zeneca in April 1999).
FDA UNII
KXL5BC5A6F
Created by admin on Sat Dec 16 10:29:48 GMT 2023 , Edited by admin on Sat Dec 16 10:29:48 GMT 2023
PRIMARY
EPA CompTox
DTXSID80938074
Created by admin on Sat Dec 16 10:29:48 GMT 2023 , Edited by admin on Sat Dec 16 10:29:48 GMT 2023
PRIMARY
CAS
171964-73-1
Created by admin on Sat Dec 16 10:29:48 GMT 2023 , Edited by admin on Sat Dec 16 10:29:48 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY